Test/Investigation
Insulin-like Growth Factor 1 (IGF-1)
Site(s) or Laboratory offering Test/Investigation
NNUH
Units
nmol/L
Sample type
Serum
Turnaround times (TAT) Urgent/Routine/GP or OPD
10 working days
Reference intervals (adult unless stated)
Male (Female) nmol/L
0–1yr 1.7-18.1 (2.1-18.7)
1 yr 2.4-23.1 (2.5-21)
2 yr 3-27.8 (2.9-23.3)
3 yr 3.7-32.4 (3.3-25.9)
4 yr 4.5-36.9 (3.8-28.7)
5 yr 5.2-41.4 (4.5-32)
6 yr 6-45.7 (5.1-35.5)
7 yr 6.9-50 (5.9-39.6)
8 yr 7.9-54.2 (6.8-44)
9 yr 8.9-58 (7.7-48.6)
10yr 9.8-61.4 (8.8-53.3)
11yr 10.9-64.2 (9.8-57.6)
12yr 11.8-66.2 (10.7-61.2)
13yr 12.6-67.3 (11.7-63.9)
14yr 13.2-67.6 (12.3-65.6)
15yr 13.6-67.1 (12.8-66.2)
16yr 14-65.8 (13.2-65.8)
17yr 14.3-63.9 (13.4-64.6)
18yr 14.3-61.8 (13.5-62.6)
19yr 14.3-59.3 (13.4-60.4)
20-29yr M: 11.3-56.6
F: (10-57.8)
30-39yr M: 9.6-32.8
F: (8.6-35.1)
40-49yr M: 7.9-27.5
F: (7.1-28.8)
50-59yr M: 6.4-25.8
F: (5.8-24.8)
If UKAS Accredited Test indicate at which site
Y NNUH